July 10, 2006 |
The number of people with a dangerous heart arrhythmia is higher than previously estimated and increasing, researchers have found. In a study of Minnesota residents, the incidence of atrial fibrillation rose more than 12% between 1980 and 2000, said the study, which was released online July 3 and appears in the July 4 print version of Circulation: Journal of the American Heart Assn. At that rate, the number of U.S.
January 10, 2005 |
Pricey pacemakers that regulate the heart's upper and lower chambers separately may be worth the extra cost because they help keep patients out of the hospital. The fancier dual-chamber models cost about $3,000 more than single-chamber devices and do not help patients live any longer on average, but do save money over time, a government-funded study has found.
November 18, 2010 |
Pfizer Inc. and Bristol-Myers Squibb said late Thursday that they were terminating a study of the experimental blood thinner apixaban prematurely because the drug was showing no benefits and was producing excess bleeding among patients receiving it. The study, called APPRAISE-2, was testing the drug in 10,800 patients with acute coronary syndrome, a group of problems characterized by chest pain caused by insufficient blood supply to the heart muscle....
May 1, 2000 |
When former Democratic candidate presidential candidate Bill Bradley announced he had a heart condition known as atrial fibrillation, some people wondered about his ability to lead the nation. Bradley's doctors said he was in excellent physical condition and that in his case, the condition--which causes an irregular heartbeat--was not a serious health hazard. (Former President Bush was treated earlier this year for the condition as well.) Health interviewed Dr. Bramah N.
December 6, 2006 |
Edwards Lifesciences Corp. said that it had dropped its laser treatment for a type of abnormal heart rhythm and that it would cut 70 jobs and take a $16-million pretax charge as it reorganized operations. Irvine-based Edwards, best known as a maker of heart valves, said it discontinued its Optiwave 980 Cardiac Laser Ablation system designed to treat atrial fibrillation, a common but difficult-to-treat heart rhythm in which the upper chambers of the heart beat out of sync.
June 14, 1991 |
King Hussein returned home Thursday after being treated for a heart ailment. The 55-year-old monarch emerged from the Hussein Medical City to the cheers of thousands of Jordanians. Cardiac surgeon Yousef Qsous said the king was in "perfect health condition and the rate of his majesty's heartbeat is normal now. But his majesty must be kept away from work and any type of exhaustion."
CALIFORNIA | LOCAL
December 3, 1990 |
Low doses of blood-thinning drugs are highly effective in reducing the risk of strokes caused by abnormal heartbeats, a study confirms. Such strokes afflict 75,000 Americans annually. In March, a major study found that a single daily aspirin tablet dramatically reduced strokes triggered by atrial fibrillation, abnormally rapid beating of the heart's upper chambers.
February 26, 2000 |
A cheerful and joking former President Bush left a Florida hospital Friday for one in Houston after spending the night for treatment of an irregular heartbeat. Bush, 75, called his condition "much ado about not much." He had complained about lightheadedness at a photo opportunity in Naples, Fla., Thursday afternoon. He spent the night at Naples Community Hospital, then flew to Houston around midday before checking into Methodist Hospital here for more tests.
October 9, 2013 |
Having a stroke, or even a transient ischemic attack (a TIA, often called a "mini-stroke") can be a costly watershed in a person's life. Statistically, it deducts years from patients' lives. But it claims another toll too: in quality of life after the stroke has happened. New research tallies the combined cost of those two very different measures, and suggests that current treatments for stroke aren't doing nearly enough to minimize strokes' true cost. The study, published Wednesday in the journal Neurology, is an exercise in health economics that seeks to generate a fuller picture of a disease's cost.